Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jack Qian, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hosny A, Bitterman DS, Guthier CV, Qian JM, Roberts H, Perni S, Saraf A, Peng LC, Pashtan I, Ye Z, Kann BH, Kozono DE, Christiani D, Catalano PJ, Aerts HJWL, Mak RH. Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study. Lancet Digit Health. 2022 09; 4(9):e657-e666. PMID: 36028289; PMCID: PMC9435511.
    Citations:    Fields:    Translation:Humans
  2. Mahmood U, Huynh MA, Killoran JH, Qian JM, Bent EH, Aizer AA, Mak RH, Mamon HJ, Balboni TA, Gunasti L, Ott PA, Awad MM, Schoenfeld JD. Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade. Int J Radiat Oncol Biol Phys. 2022 11 15; 114(4):666-675. PMID: 35643252.
    Citations: 1     Fields:    
  3. Ye Z, Qian JM, Hosny A, Zeleznik R, Plana D, Likitlersuang J, Zhang Z, Mak RH, Aerts HJWL, Kann BH. Deep Learning-based Detection of Intravenous Contrast Enhancement on CT Scans. Radiol Artif Intell. 2022 May; 4(3):e210285. PMID: 35652117; PMCID: PMC9152686.
    Citations:    
  4. Qian JM, Akama-Garren E, Shin J, Gunasti L, Bang A, Pike LRG, Grassberger C, Schoenfeld JD. Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors. Adv Radiat Oncol. 2022 Mar-Apr; 7(2):100880. PMID: 35097241; PMCID: PMC8783121.
    Citations:    
  5. Qian JM, Schoenfeld JD. Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges. Front Oncol. 2020; 10:608772. PMID: 33614492.
    Citations: 7     
  6. Qian JM, Martin AM, Martin K, Hammoudeh L, Catalano PJ, Hodi FS, Cagney DN, Haas-Kogan DA, Schoenfeld JD, Aizer AA. Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases. Cancer. 2020 12 15; 126(24):5274-5282. PMID: 32926760.
    Citations: 5     Fields:    Translation:Humans
  7. Kim DW, Lee G, Lee H, Qian JM, Sanford NN, Lam MB, Tahir N, Mamon HJ. Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer. Adv Radiat Oncol. 2020 May-Jun; 5(3):516-521. PMID: 32529149; PMCID: PMC7276683.
    Citations:    
  8. Qian JM, Yu JB, Mahajan A, Goldberg SB, Kluger HM, Chiang VLS. Frequent Use of Local Therapy Underscores Need for Multidisciplinary Care in the Management of Patients With Melanoma Brain Metastases Treated With PD-1 Inhibitors. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1113-1118. PMID: 31479702.
    Citations: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  9. Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, Taylor DG, Kondziolka D, Warnick R, Chiang V, Sheehan J. BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study. Neurosurgery. 2019 04 01; 84(4):868-880. PMID: 29846702; PMCID: PMC6505443.
    Citations: 16     Fields:    Translation:Humans
  10. Singh C, Qian JM, Yu JB, Chiang VL. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases. J Neurosurg. 2019 02 15; 132(2):512-517. PMID: 30771783.
    Citations: 27     Fields:    Translation:Humans
  11. Stahl JM, Qian JM, Tien CJ, Carlson DJ, Chen Z, Ratner ES, Park HS, Damast S. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. Support Care Cancer. 2019 Apr; 27(4):1425-1433. PMID: 30187220.
    Citations: 5     Fields:    Translation:Humans
  12. Qian JM, Stahl JM, Young MR, Ratner E, Damast S. Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer. J Gynecol Oncol. 2017 Nov; 28(6):e84. PMID: 29027402.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  13. An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017 10; 125(1):80-88. PMID: 28916225.
    Citations: 21     Fields:    Translation:Humans
  14. Qian JM, Mahajan A, Yu JB, Tsiouris AJ, Goldberg SB, Kluger HM, Chiang VLS. Comparing available criteria for measuring brain metastasis response to immunotherapy. J Neurooncol. 2017 05; 132(3):479-485. PMID: 28275886.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  15. Qian JM, Yu JB, Kluger HM, Chiang VL. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery. Cancer. 2016 10; 122(19):3051-8. PMID: 27285122; PMCID: PMC5030143.
    Citations: 85     Fields:    Translation:HumansCells
  16. Taylor BF, Knisely JP, Qian JM, Yu JB, Chiang VL. Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics. J Radiosurg SBRT. 2016; 4(1):53-60. PMID: 29296426; PMCID: PMC5658837.
    Citations:    
  17. Stachelek GC, Peterson-Roth E, Liu Y, Fernandez RJ, Pike LR, Qian JM, Abriola L, Hoyer D, Hungerford W, Merkel J, Glazer PM. YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors. Mol Cancer Res. 2015 Oct; 13(10):1389-97. PMID: 26116172; PMCID: PMC4618103.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  18. Hughes ME, Grant GR, Paquin C, Qian J, Nitabach MN. Deep sequencing the circadian and diurnal transcriptome of Drosophila brain. Genome Res. 2012 Jul; 22(7):1266-81. PMID: 22472103.
    Citations: 92     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Qian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (99)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.